A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1
Clinical trial NCT03277456 · COMPLETED
Trial details
- NCT number
- NCT03277456
- Sponsor
- Barinthus Biotherapeutics
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2017-11-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.